News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/Candida-albicans.jpg)
FDA grants rezafungin QIDP and fast track designations
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/doctor_consults_with_cancer_patient_and_her_father_Credit_Rhoda_Baer_220.jpg)
Factors that may drive relapse in AYAs with ALL
- Author:
- HT Staff
New research suggests race, clinical trial participation, and treatment duration may influence the risk of relapse in adolescents and young adults...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/arina-ten-cate-hoek-maastricht-230.jpg)
Study supports immediate compression after DVT
- Author:
- HT Staff
Immediate compression therapy provides a “clear benefit” for patients with deep vein thrombosis (DVT), according to the senior author of a study...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/HSCs_being_prepared_for_transplant_credit_Chad_McNeeley_230.jpg)
Placenta-derived product receives orphan designation for HSCT
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/preparing_capsules_for_a_clinical_trial_credit_Esther_Dyson_230.jpg)
FDA lifts partial hold on tazemetostat trials
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/blinatumomab-vials-blincyto-amgen-220.jpg)
Blinatumomab approved to treat ALL in Japan
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare has approved blinatumomab (Blincyto®) for the treatment of relapsed or refractory B-cell acute...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/CLL_cells.jpg)
FDA approves duvelisib for CLL/SLL and FL
- Author:
- HT Staff
The U.S.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/AML_cells_Credit_Lance_Liotta_230.jpg)
FLT3 inhibitor approved for rel/ref AML in Japan
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the FLT3 inhibitor gilteritinib (Xospata®) to treat patients with FLT3-...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/brentuximab-vedotin-businesswire-230.png)
Drug approved as part of frontline therapy for HL
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare has approved brentuximab vedotin (Adcetris) in combination with doxorubicin, vinblastine, and...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/jivi_bayer-210.jpg)
Product approved to treat hemophilia A in Japan
- Author:
- HT Staff
The Japanese Ministry of Health, Labour and Welfare has approved Jivi® (also known as damoctocog alfa pegol or antihemophilic factor [recombinant...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/blinatumomab-vials-blincyto-amgen-220.jpg)
CHMP reconsiders new indication for blinatumomab
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) said it will re-examine a recent opinion on blinatumomab (...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/neulasta-onpro-kit-amgen-230.jpg)
CHMP backs proposed biosimilars of pegfilgrastim
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for three proposed biosimilars of...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/jivi_bayer-210.jpg)
CHMP recommends factor VIII therapy for hemophilia A
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for damoctocog alfa pegol, a...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/venclexta-month-Abbvie-220.jpg)
CHMP supports new indication for venetoclax
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) approve a...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/images/articles/hemtimes/mycosis_fungoides_micrograph_showing_230.jpg)
CHMP recommends mogamulizumab for MF, SS
- Author:
- HT Staff
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval for mogamulizumab (Poteligeo)....